Anneke Blom

Anneke Blom is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as the Head of Research and Development at Nanomi since February 2025. Prior experience includes roles as Director of Chemistry, Manufacturing & Control at Venn Life Sciences from April 2016 to February 2025, and various positions at MSD, Patheon, and OctoPlus, where responsibilities encompassed project management, CMC development, and technology transfer among others. Anneke co-founded CoVaccine B.V., focusing on vaccine adjuvants, and has a solid academic background with degrees in Medical Histology and VWO. Continuous professional development includes various courses in management and the pharmaceutical field.